IMAX holder files Form 144 to sell 50,143 shares on NYSE

Rhea-AI Filing Summary

IMAX — Form 144 notice of proposed sale: A holder filed to sell up to 50,143 shares of Class A Common on or about 11/07/2025 through Merrill Lynch on the NYSE, reflecting an aggregate market value of 1,738,215.

The shares to be sold were acquired on 11/07/2025 via an exercise of options under a registered plan, paid in cash. Over the prior three months, the person reported selling 20,000 shares on 09/15/2025 for gross proceeds of 656,029. Shares outstanding were 53,798,934.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Shares	Merrill Lynch One Bryant Park, 28th Floor New York NY 10036	50143	1738215	53798934	11/07/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	11/07/2025	Exercise of options under a registered plan	Issuer			50143	11/07/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert D. Lister 902 Broadway FL 20 New York NY 10010	Class A Common	09/15/2025	20000	656029

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did IMAX (IMAX) disclose in this Form 144?

A holder filed a notice to sell up to 50,143 Class A Common shares on or about 11/07/2025 on the NYSE through Merrill Lynch.

What is the aggregate market value of the proposed IMAX share sale?

The filing lists an aggregate market value of 1,738,215 for the 50,143 shares.

How were the IMAX shares to be sold acquired?

They were acquired on 11/07/2025 via an exercise of options under a registered plan, paid in cash.

Which broker and exchange are named for the IMAX share sale?

The broker is Merrill Lynch and the exchange is the NYSE.

Were there recent sales by the same person in the last 3 months?

Yes. The filing reports a sale of 20,000 shares on 09/15/2025 with gross proceeds of 656,029.

How many IMAX shares are outstanding per the filing?

The filing lists 53,798,934 shares outstanding.